Table 3.
Treatment Group | Pre-treatment | Post-treatment | ||
---|---|---|---|---|
Serum Glucose (mg/dL)
|
||||
Fasting | 2-h Post | Fasting | 2-h Post | |
|
||||
Control | 103.22 ± 8.32 | 108.17 ± 36.56 | 99.94 ± 8.21** | 103.94 ± 34.05 |
TIB Restriction | 99.27 ± 9.26 | 97.23 ± 29.63 | 100.41 ± 9.03** | 90.82 ± 20.70 |
|
||||
Serum Insulin (mU/L)
|
||||
Fasting | 2-h Post | Fasting | 2-h Post | |
|
||||
Control | 9.93 ± 5.59* | 68.12 ± 70.83 | 8.93 ± 5.43 | 61.81 ± 59.71 |
TIB Restriction | 5.51 ± 1.92* | 37.98 ± 29.95 | 6.27 ± 3.39 | 32.57 ± 28.30 |
Values are Mean ± SD. 2-h Post: assessment 2 h following initial glucose ingestion (75 g).
Significant pre-treatment difference between treatment groups (P < 0.05).
Significant post-treatment difference between treatment groups (following control for baseline BMI and baseline values) (P < 0.05).